{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P49913",
      "entity_text" : "cAMP",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02260",
      "entity_text" : "DMF",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "In addition to its widely reported activation of Nrf2 in CNS cells, in vitro DMF treatment of peripheral immune cells has been shown to affect NF-kappaB activation and production of a variety of inflammatory mediators; we have previously demonstrated that DMF stimulates production of the immunomodulator cAMP via the prostaglandin E2 receptor in PBMCs, but only at relatively high concentrations of DMF [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-02T14:55:25Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:53:03Z",
  "trigger" : "stimulates",
  "evidence" : [ "DMF stimulates production of the immunomodulator cAMP" ],
  "pmc_id" : "5669026",
  "score" : 0
}